Philip W. Dockery

Researcher

University of Arkansas for Medical Sciences

faculty

9 h-index 42 pubs 277 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Philip W. Dockery's research focuses on ophthalmic conditions, particularly melanoma and retinoblastoma. His work has investigated the mutational landscape and outcomes associated with conjunctival melanoma, analyzing large patient cohorts to understand factors influencing recurrence, metastasis, and death. Dockery has also studied intra-arterial chemotherapy for retinoblastoma, comparing outcomes based on patient demographics and examining the likelihood of germline mutations in relation to patient age at presentation. His publications also address corneal procedures and the assessment of choroidal nevus progression risk using ophthalmic imaging. Dockery has a h-index of 9, with 42 publications and 277 citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Tom Kornhauser, John D. Pemberton, Wade Brock, and Christian Ponder.

Metrics

  • h-index: 9
  • Publications: 42
  • Citations: 277

Selected Publications

  • Primary suspect drugs of cataracts in pediatric patients: FDA adverse events reporting database analysis (2025) DOI
  • Timing of Jones Tube Placement After Excision of Nasal or Lacrimal Drainage System Malignancy: A Survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) (2023) DOI
  • Complete Fibrin Degradation 1 Day after Intracameral Alteplase (2023) DOI
  • Clinical outcomes of Descemet membrane endothelial keratoplasty performed in eyes with keratoconus and corneal endothelial dysfunction (2022) DOI
  • Reply to: “Is there a genetic link between Keratoconus and Fuch’s endothelial corneal dystrophy?” (2022) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics